GCM
MED icon

Gladius Capital Management’s Medifast MED Stock Holding History

Gladius Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,448
Closed -$75.2K – 332
2024
Q2 		$75.2K Buy
3,448
+289
+9% +$7.7K 0.01% 160
2024
Q1 		$121K Buy
+3,159
New +$153K 0.04% 143
2022
Q2 		– Sell
-541
Closed -$93K – 393
2022
Q1 		$93K Buy
541
+84
+18% +$15.8K 0.01% 231
2021
Q4 		$96K Buy
+457
New +$94.5K 0.01% 258

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gladius Capital Management's MED Position: Q3 2024 in Review

Gladius Capital Management sold out of Medifast (MED) in Q3 2024, closing a stake of 3,448 shares — an estimated $75.2K sold.

Gladius Capital Management first reported a position in MED in Q4 2021 and held it in 4 quarters. The position peaked at $121K in Q1 2024. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

  • Gladius Capital Management reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,448 Medifast shares in Q3 2024, an estimated $75.2K.
  • Gladius Capital Management first reported a position in Medifast in Q4 2021 and held it in 4 quarters.
  • Gladius Capital Management's Medifast position peaked at $121K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.